Lymphocyte Function Alteration [PE] - N0000178327

Pharmacologic Class Information

Pharmacologic Code N0000178327
Pharmacologic Name Lymphocyte Function Alteration
Pharmacologic Uses
  • immunoglobulin G
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Lymphocyte Function Alteration

The table contains 5 products whose active ingredient are classified under the same pharmacologic class Lymphocyte Function Alteration [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0009-7224Atgam Non-Proprietary Name: Equine Thymocyte Immune GlobulinInjection, SolutionIntravenousPharmacia & Upjohn Company LlcACTIVE
48951-6050Lymphocytes 8 Non-Proprietary Name: Lymphocytes 8LiquidOralUriel Pharmacy Inc.ACTIVE
48951-6060Lymphocytes 30 Special Order Non-Proprietary Name: Lymphocytes 30 Special OrderLiquidOralUriel Pharmacy Inc.ACTIVE
48951-6080Lymphocytes 6x Non-Proprietary Name: Lymphocytes 6xLiquidOralUriel Pharmacy Inc.ACTIVE
58468-0080Thymoglobulin Non-Proprietary Name: Anti-thymocyte Globulin (rabbit)Injection, Powder, Lyophilized, For SolutionIntravenousGenzyme CorporationACTIVE